About: Triple therapy and proton pump inhibitors had lowest costs and best outcomes for Helicobacter pylori infection

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : Triple therapy and proton pump inhibitors had lowest costs and best outcomes for Helicobacter pylori infection Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Article
Is Part Of	http://hub.abes.fr/bmj/periodical/ebm/1997/volume_2/issue_4/w
Subject	Economics
Title	Triple therapy and proton pump inhibitors had lowest costs and best outcomes for Helicobacter pylori infection
has manifestation of work	http://hub.abes.fr/bmj/periodical/ebm/1997/volume_2/issue_4/B3555EDB43FA38C5E053120B220A16A6/m/print http://hub.abes.fr/bmj/periodical/ebm/1997/volume_2/issue_4/B3555EDB43FA38C5E053120B220A16A6/m/web
Abstract	TaylorJLZagariMMurphyKFrestonJW. Pharmacoeconomic comparison of treatments for the eradication, of Helicobacter pylori. Arch Intern Med. 1997 Jan 13;157:87-97.
article type	other
publisher identifier	ebmed2128
is part of this journal	Evidence Based Medicine

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata